Literature DB >> 11907335

Human herpesvirus-6 rep/U94 gene product has single-stranded DNA-binding activity.

Panadda Dhepakson1, Yasuko Mori1, Yun Bao Jiang1, Hong Lan Huang1, Pilailuk Akkapaiboon1, Toshiomi Okuno2, Koichi Yamanishi1.   

Abstract

The characterization is reported of the human herpesvirus-6B (HHV-6B) rep/U94 gene, which is a homologue of the adeno-associated virus type 2 rep. In this study, a monoclonal antibody was produced against HHV-6B REP (anti-REP mAb). Immunofluorescence staining using the anti-REP mAb showed that REP was localized to the nucleus in HHV-6-infected MT4 cells. It was first detected at 24 h post-infection (p.i.) and accumulated to higher levels by 72 h p.i. REP may be expressed only at very low levels in HHV-6-infected cells: even when the late protein glycoprotein H was detected in nearly 90% of HHV-6-infected cells, REP was detected in only a small percentage of them. Western blot analysis showed that the anti-REP mAb recognized a 56-kDa polypeptide in HHV-6B-infected MT4 cells. Furthermore, the REP protein was shown to bind single-stranded DNA.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11907335     DOI: 10.1099/0022-1317-83-4-847

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  26 in total

1.  Analysis of a neutralizing antibody for human herpesvirus 6B reveals a role for glycoprotein Q1 in viral entry.

Authors:  Akiko Kawabata; Hiroko Oyaizu; Takahiro Maeki; Huamin Tang; Koichi Yamanishi; Yasuko Mori
Journal:  J Virol       Date:  2011-09-28       Impact factor: 5.103

Review 2.  Roseolovirus molecular biology: recent advances.

Authors:  Laurie T Krug; Philip E Pellett
Journal:  Curr Opin Virol       Date:  2014-11-27       Impact factor: 7.090

3.  Detailed study of the interaction between human herpesvirus 6B glycoprotein complex and its cellular receptor, human CD134.

Authors:  Huamin Tang; Junjie Wang; Nora F Mahmoud; Yasuko Mori
Journal:  J Virol       Date:  2014-07-09       Impact factor: 5.103

4.  Role of the short telomeric repeat region in Marek's disease virus replication, genomic integration, and lymphomagenesis.

Authors:  Annachiara Greco; Nadine Fester; Annemarie T Engel; Benedikt B Kaufer
Journal:  J Virol       Date:  2014-10-01       Impact factor: 5.103

Review 5.  Update on human herpesvirus 6 biology, clinical features, and therapy.

Authors:  Leen De Bolle; Lieve Naesens; Erik De Clercq
Journal:  Clin Microbiol Rev       Date:  2005-01       Impact factor: 26.132

6.  The Neutralizing Linear Epitope of Human Herpesvirus 6A Glycoprotein B Does Not Affect Virus Infectivity.

Authors:  Aika Wakata; Satoshi Kanemoto; Huamin Tang; Akiko Kawabata; Mitsuhiro Nishimura; Chyntia Jasirwan; Nora Fahmy Mahmoud; Yasuko Mori
Journal:  J Virol       Date:  2018-02-12       Impact factor: 5.103

7.  gp96 Is Critical for both Human Herpesvirus 6A (HHV-6A) and HHV-6B Infections.

Authors:  Jingjing Ma; Junli Jia; Xuefeng Jiang; Mengyuan Xu; Jinfeng Guo; Tian Tang; Xianyi Xu; Zhisheng Wu; Benshun Hu; Kun Yao; Lingyun Li; Huamin Tang
Journal:  J Virol       Date:  2020-06-16       Impact factor: 5.103

8.  Intracellular processing of human herpesvirus 6 glycoproteins Q1 and Q2 into tetrameric complexes expressed on the viral envelope.

Authors:  Pilailuk Akkapaiboon; Yasuko Mori; Tomohiko Sadaoka; Sayoko Yonemoto; Koichi Yamanishi
Journal:  J Virol       Date:  2004-08       Impact factor: 5.103

9.  Discovery of a second form of tripartite complex containing gH-gL of human herpesvirus 6 and observations on CD46.

Authors:  Yasuko Mori; Pilailuk Akkapaiboon; Sayoko Yonemoto; Masato Koike; Masaya Takemoto; Tomohiko Sadaoka; Yumi Sasamoto; Shozo Konishi; Yasuo Uchiyama; Koichi Yamanishi
Journal:  J Virol       Date:  2004-05       Impact factor: 5.103

10.  y Human herpesvirus 6 envelope components enriched in lipid rafts: evidence for virion-associated lipid rafts.

Authors:  Akiko Kawabata; Huamin Tang; Honglan Huang; Koichi Yamanishi; Yasuko Mori
Journal:  Virol J       Date:  2009-08-19       Impact factor: 4.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.